Mylab launches CoviSwift for Covid-19 Point of Care testing
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
It has a total of 50 ANDA approvals from USFDA
The need is to vaccinate people who have not contracted Covid-19
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
Subscribe To Our Newsletter & Stay Updated